Loading…

Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits

The present study investigated the efficacy of allicin as an antibacterial, anti-inflammatory, antioxidant, and immunostimulant agent in reducing the severity of Pasteurella multocida (P. multocida) type B infection in rabbits. Fifty New Zealand rabbits, 5 weeks old, were divided equally into five g...

Full description

Saved in:
Bibliographic Details
Published in:Oxidative medicine and cellular longevity 2018-01, Vol.2018 (2018), p.1-10
Main Authors: Aleya, Lotfi, Alansari, Wafa S., Alkhalf, Maha I., Fawzi, Elshaima M., Alam, Rasha T. M., Abdel-Daim, Mohamed M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3
cites cdi_FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3
container_end_page 10
container_issue 2018
container_start_page 1
container_title Oxidative medicine and cellular longevity
container_volume 2018
creator Aleya, Lotfi
Alansari, Wafa S.
Alkhalf, Maha I.
Fawzi, Elshaima M.
Alam, Rasha T. M.
Abdel-Daim, Mohamed M.
description The present study investigated the efficacy of allicin as an antibacterial, anti-inflammatory, antioxidant, and immunostimulant agent in reducing the severity of Pasteurella multocida (P. multocida) type B infection in rabbits. Fifty New Zealand rabbits, 5 weeks old, were divided equally into five groups. Except for group 1, all groups were intranasally infected with P. multocida type B (2 × 105 colony forming units/ml/rabbit). Then, group 3 rabbits were orally treated with allicin (50 mg/kg BW) for 5 days, group 4 rabbits received a single oral dose of norfloxacin 30% (100 mg/kg BW), while group 5 rabbits were treated with a combination of norfloxacin and allicin. Hematological, serum biochemical, inflammatory cytokine, immunological, and histopathological analyses were performed. Results revealed that rabbits, infected with P. multocida type B, exhibited macrocytic hypochromic anemia and leukocytosis with a significant elevation in the phagocytic percentage and index. Moreover, significant reductions in serum total protein, albumin, globulin, and immunoglobulin (IgG and IgM) levels were observed in infected rabbits. Infected rabbits showed significant increases in serum inflammatory cytokine (TNF-α and IL-6), alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, and serum bilirubin (total, direct, and indirect) levels. Further, P. multocida infection induced oxidative stress as demonstrated by the significant reduction in serum levels of reduced glutathione and superoxide dismutase enzyme and marked elevation in serum malondialdehyde. Treatment with allicin, norfloxacin, or their combination significantly ameliorated the alterations in all studied parameters. In conclusion, allicin could ameliorate the inflammation and oxidative stress, induced by P. multocida type B infection in rabbits.
doi_str_mv 10.1155/2018/1780956
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6040273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2078582391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoh9w44wscQGxS8d2krUvSKtVoSstBaFy4RJNEqfryrGL7Wzbn8U_xOkuC_TEyfb4mdfvjCfLXlB4R2lRnDCg4oTOBMiifJQdUpmzKUiZP97vAQ6yoxCuAErOcvo0O-AABZR5cZj9nNuop0vbGex7jM7fTciy7wfretcOZhdB25IRdLe6RRvJvIl6o6NWgbiOzI3RjbYTcu58Z9wt3h-cJxdrpT1ZuL7WFlO2JXiJ2oZIvmCIavDKGCT9YKJrkjBJNlRzz2lLPqFR5FzdkO8KzWjgK9a1juFZ9qRDE9Tz3XqcfftwerE4m64-f1wu5qtpU0ARp61itOVMgpBSoCoKUEzJmeCc59AxRnOKWNRixqhA2gqGnZKMybbmKgfR8ePs_Vb3eqh71TbKRo-muva6R39XOdTVvzdWr6tLt6lKyIHNeBJ4sxVYP0g7m6-qMZY-Lnkp5YYm9vXuMe9-DCrEqtehGdtjlRtCxWAmCsG4HNFXD9ArN3ibWpGosuRQMhCJmmypxrsQvOr2DihU49xU49xUu7lJ-Mu_i93DvwclAW93xWjb4o3-TzmVGNXhH5pRkDTnvwDRqtYr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2066306208</pqid></control><display><type>article</type><title>Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><creator>Aleya, Lotfi ; Alansari, Wafa S. ; Alkhalf, Maha I. ; Fawzi, Elshaima M. ; Alam, Rasha T. M. ; Abdel-Daim, Mohamed M.</creator><contributor>Sandhu, Mansur A. ; Mansur A Sandhu</contributor><creatorcontrib>Aleya, Lotfi ; Alansari, Wafa S. ; Alkhalf, Maha I. ; Fawzi, Elshaima M. ; Alam, Rasha T. M. ; Abdel-Daim, Mohamed M. ; Sandhu, Mansur A. ; Mansur A Sandhu</creatorcontrib><description>The present study investigated the efficacy of allicin as an antibacterial, anti-inflammatory, antioxidant, and immunostimulant agent in reducing the severity of Pasteurella multocida (P. multocida) type B infection in rabbits. Fifty New Zealand rabbits, 5 weeks old, were divided equally into five groups. Except for group 1, all groups were intranasally infected with P. multocida type B (2 × 105 colony forming units/ml/rabbit). Then, group 3 rabbits were orally treated with allicin (50 mg/kg BW) for 5 days, group 4 rabbits received a single oral dose of norfloxacin 30% (100 mg/kg BW), while group 5 rabbits were treated with a combination of norfloxacin and allicin. Hematological, serum biochemical, inflammatory cytokine, immunological, and histopathological analyses were performed. Results revealed that rabbits, infected with P. multocida type B, exhibited macrocytic hypochromic anemia and leukocytosis with a significant elevation in the phagocytic percentage and index. Moreover, significant reductions in serum total protein, albumin, globulin, and immunoglobulin (IgG and IgM) levels were observed in infected rabbits. Infected rabbits showed significant increases in serum inflammatory cytokine (TNF-α and IL-6), alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, and serum bilirubin (total, direct, and indirect) levels. Further, P. multocida infection induced oxidative stress as demonstrated by the significant reduction in serum levels of reduced glutathione and superoxide dismutase enzyme and marked elevation in serum malondialdehyde. Treatment with allicin, norfloxacin, or their combination significantly ameliorated the alterations in all studied parameters. In conclusion, allicin could ameliorate the inflammation and oxidative stress, induced by P. multocida type B infection in rabbits.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2018/1780956</identifier><identifier>PMID: 30050645</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Alanine Transaminase - blood ; Albumins - metabolism ; Alkaline Phosphatase - blood ; Animals ; Anti-Inflammatory Agents - therapeutic use ; Antibiotics ; Anticoagulants ; Antioxidants ; Antioxidants - therapeutic use ; Bacterial infections ; Bilirubin - blood ; Dehydrogenases ; Drug dosages ; Environmental Sciences ; Experiments ; Garlic ; Globulins - metabolism ; Hematology ; Immunization ; Immunoglobulin G - blood ; Immunoglobulin M - blood ; Immunoglobulins ; Immunomodulators ; Infections ; Interleukin-6 - blood ; L-Lactate Dehydrogenase - blood ; Laboratory animals ; Male ; Malondialdehyde - blood ; Norfloxacin - therapeutic use ; Nutrition ; Oxidative stress ; Pasteurella Infections - blood ; Pasteurella Infections - drug therapy ; Pasteurella multocida - drug effects ; Pasteurella multocida - pathogenicity ; Rabbits ; Rodents ; Sulfinic Acids - therapeutic use ; Superoxide Dismutase - blood ; Tumor Necrosis Factor-alpha - blood ; Tumor necrosis factor-TNF ; Veterinary medicine</subject><ispartof>Oxidative medicine and cellular longevity, 2018-01, Vol.2018 (2018), p.1-10</ispartof><rights>Copyright © 2018 Rasha T. M. Alam et al.</rights><rights>Copyright © 2018 Rasha T. M. Alam et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2018 Rasha T. M. Alam et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3</citedby><cites>FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3</cites><orcidid>0000-0002-4341-2713 ; 0000-0001-9742-4368</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2066306208/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2066306208?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,25731,27901,27902,36989,36990,44566,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30050645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01834069$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Sandhu, Mansur A.</contributor><contributor>Mansur A Sandhu</contributor><creatorcontrib>Aleya, Lotfi</creatorcontrib><creatorcontrib>Alansari, Wafa S.</creatorcontrib><creatorcontrib>Alkhalf, Maha I.</creatorcontrib><creatorcontrib>Fawzi, Elshaima M.</creatorcontrib><creatorcontrib>Alam, Rasha T. M.</creatorcontrib><creatorcontrib>Abdel-Daim, Mohamed M.</creatorcontrib><title>Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>The present study investigated the efficacy of allicin as an antibacterial, anti-inflammatory, antioxidant, and immunostimulant agent in reducing the severity of Pasteurella multocida (P. multocida) type B infection in rabbits. Fifty New Zealand rabbits, 5 weeks old, were divided equally into five groups. Except for group 1, all groups were intranasally infected with P. multocida type B (2 × 105 colony forming units/ml/rabbit). Then, group 3 rabbits were orally treated with allicin (50 mg/kg BW) for 5 days, group 4 rabbits received a single oral dose of norfloxacin 30% (100 mg/kg BW), while group 5 rabbits were treated with a combination of norfloxacin and allicin. Hematological, serum biochemical, inflammatory cytokine, immunological, and histopathological analyses were performed. Results revealed that rabbits, infected with P. multocida type B, exhibited macrocytic hypochromic anemia and leukocytosis with a significant elevation in the phagocytic percentage and index. Moreover, significant reductions in serum total protein, albumin, globulin, and immunoglobulin (IgG and IgM) levels were observed in infected rabbits. Infected rabbits showed significant increases in serum inflammatory cytokine (TNF-α and IL-6), alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, and serum bilirubin (total, direct, and indirect) levels. Further, P. multocida infection induced oxidative stress as demonstrated by the significant reduction in serum levels of reduced glutathione and superoxide dismutase enzyme and marked elevation in serum malondialdehyde. Treatment with allicin, norfloxacin, or their combination significantly ameliorated the alterations in all studied parameters. In conclusion, allicin could ameliorate the inflammation and oxidative stress, induced by P. multocida type B infection in rabbits.</description><subject>Alanine Transaminase - blood</subject><subject>Albumins - metabolism</subject><subject>Alkaline Phosphatase - blood</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Anticoagulants</subject><subject>Antioxidants</subject><subject>Antioxidants - therapeutic use</subject><subject>Bacterial infections</subject><subject>Bilirubin - blood</subject><subject>Dehydrogenases</subject><subject>Drug dosages</subject><subject>Environmental Sciences</subject><subject>Experiments</subject><subject>Garlic</subject><subject>Globulins - metabolism</subject><subject>Hematology</subject><subject>Immunization</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M - blood</subject><subject>Immunoglobulins</subject><subject>Immunomodulators</subject><subject>Infections</subject><subject>Interleukin-6 - blood</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Laboratory animals</subject><subject>Male</subject><subject>Malondialdehyde - blood</subject><subject>Norfloxacin - therapeutic use</subject><subject>Nutrition</subject><subject>Oxidative stress</subject><subject>Pasteurella Infections - blood</subject><subject>Pasteurella Infections - drug therapy</subject><subject>Pasteurella multocida - drug effects</subject><subject>Pasteurella multocida - pathogenicity</subject><subject>Rabbits</subject><subject>Rodents</subject><subject>Sulfinic Acids - therapeutic use</subject><subject>Superoxide Dismutase - blood</subject><subject>Tumor Necrosis Factor-alpha - blood</subject><subject>Tumor necrosis factor-TNF</subject><subject>Veterinary medicine</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk1v1DAQhiMEoh9w44wscQGxS8d2krUvSKtVoSstBaFy4RJNEqfryrGL7Wzbn8U_xOkuC_TEyfb4mdfvjCfLXlB4R2lRnDCg4oTOBMiifJQdUpmzKUiZP97vAQ6yoxCuAErOcvo0O-AABZR5cZj9nNuop0vbGex7jM7fTciy7wfretcOZhdB25IRdLe6RRvJvIl6o6NWgbiOzI3RjbYTcu58Z9wt3h-cJxdrpT1ZuL7WFlO2JXiJ2oZIvmCIavDKGCT9YKJrkjBJNlRzz2lLPqFR5FzdkO8KzWjgK9a1juFZ9qRDE9Tz3XqcfftwerE4m64-f1wu5qtpU0ARp61itOVMgpBSoCoKUEzJmeCc59AxRnOKWNRixqhA2gqGnZKMybbmKgfR8ePs_Vb3eqh71TbKRo-muva6R39XOdTVvzdWr6tLt6lKyIHNeBJ4sxVYP0g7m6-qMZY-Lnkp5YYm9vXuMe9-DCrEqtehGdtjlRtCxWAmCsG4HNFXD9ArN3ibWpGosuRQMhCJmmypxrsQvOr2DihU49xU49xUu7lJ-Mu_i93DvwclAW93xWjb4o3-TzmVGNXhH5pRkDTnvwDRqtYr</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Aleya, Lotfi</creator><creator>Alansari, Wafa S.</creator><creator>Alkhalf, Maha I.</creator><creator>Fawzi, Elshaima M.</creator><creator>Alam, Rasha T. M.</creator><creator>Abdel-Daim, Mohamed M.</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4341-2713</orcidid><orcidid>https://orcid.org/0000-0001-9742-4368</orcidid></search><sort><creationdate>20180101</creationdate><title>Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits</title><author>Aleya, Lotfi ; Alansari, Wafa S. ; Alkhalf, Maha I. ; Fawzi, Elshaima M. ; Alam, Rasha T. M. ; Abdel-Daim, Mohamed M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alanine Transaminase - blood</topic><topic>Albumins - metabolism</topic><topic>Alkaline Phosphatase - blood</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Anticoagulants</topic><topic>Antioxidants</topic><topic>Antioxidants - therapeutic use</topic><topic>Bacterial infections</topic><topic>Bilirubin - blood</topic><topic>Dehydrogenases</topic><topic>Drug dosages</topic><topic>Environmental Sciences</topic><topic>Experiments</topic><topic>Garlic</topic><topic>Globulins - metabolism</topic><topic>Hematology</topic><topic>Immunization</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M - blood</topic><topic>Immunoglobulins</topic><topic>Immunomodulators</topic><topic>Infections</topic><topic>Interleukin-6 - blood</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Laboratory animals</topic><topic>Male</topic><topic>Malondialdehyde - blood</topic><topic>Norfloxacin - therapeutic use</topic><topic>Nutrition</topic><topic>Oxidative stress</topic><topic>Pasteurella Infections - blood</topic><topic>Pasteurella Infections - drug therapy</topic><topic>Pasteurella multocida - drug effects</topic><topic>Pasteurella multocida - pathogenicity</topic><topic>Rabbits</topic><topic>Rodents</topic><topic>Sulfinic Acids - therapeutic use</topic><topic>Superoxide Dismutase - blood</topic><topic>Tumor Necrosis Factor-alpha - blood</topic><topic>Tumor necrosis factor-TNF</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aleya, Lotfi</creatorcontrib><creatorcontrib>Alansari, Wafa S.</creatorcontrib><creatorcontrib>Alkhalf, Maha I.</creatorcontrib><creatorcontrib>Fawzi, Elshaima M.</creatorcontrib><creatorcontrib>Alam, Rasha T. M.</creatorcontrib><creatorcontrib>Abdel-Daim, Mohamed M.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aleya, Lotfi</au><au>Alansari, Wafa S.</au><au>Alkhalf, Maha I.</au><au>Fawzi, Elshaima M.</au><au>Alam, Rasha T. M.</au><au>Abdel-Daim, Mohamed M.</au><au>Sandhu, Mansur A.</au><au>Mansur A Sandhu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>The present study investigated the efficacy of allicin as an antibacterial, anti-inflammatory, antioxidant, and immunostimulant agent in reducing the severity of Pasteurella multocida (P. multocida) type B infection in rabbits. Fifty New Zealand rabbits, 5 weeks old, were divided equally into five groups. Except for group 1, all groups were intranasally infected with P. multocida type B (2 × 105 colony forming units/ml/rabbit). Then, group 3 rabbits were orally treated with allicin (50 mg/kg BW) for 5 days, group 4 rabbits received a single oral dose of norfloxacin 30% (100 mg/kg BW), while group 5 rabbits were treated with a combination of norfloxacin and allicin. Hematological, serum biochemical, inflammatory cytokine, immunological, and histopathological analyses were performed. Results revealed that rabbits, infected with P. multocida type B, exhibited macrocytic hypochromic anemia and leukocytosis with a significant elevation in the phagocytic percentage and index. Moreover, significant reductions in serum total protein, albumin, globulin, and immunoglobulin (IgG and IgM) levels were observed in infected rabbits. Infected rabbits showed significant increases in serum inflammatory cytokine (TNF-α and IL-6), alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, and serum bilirubin (total, direct, and indirect) levels. Further, P. multocida infection induced oxidative stress as demonstrated by the significant reduction in serum levels of reduced glutathione and superoxide dismutase enzyme and marked elevation in serum malondialdehyde. Treatment with allicin, norfloxacin, or their combination significantly ameliorated the alterations in all studied parameters. In conclusion, allicin could ameliorate the inflammation and oxidative stress, induced by P. multocida type B infection in rabbits.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>30050645</pmid><doi>10.1155/2018/1780956</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4341-2713</orcidid><orcidid>https://orcid.org/0000-0001-9742-4368</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1942-0900
ispartof Oxidative medicine and cellular longevity, 2018-01, Vol.2018 (2018), p.1-10
issn 1942-0900
1942-0994
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6040273
source Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database
subjects Alanine Transaminase - blood
Albumins - metabolism
Alkaline Phosphatase - blood
Animals
Anti-Inflammatory Agents - therapeutic use
Antibiotics
Anticoagulants
Antioxidants
Antioxidants - therapeutic use
Bacterial infections
Bilirubin - blood
Dehydrogenases
Drug dosages
Environmental Sciences
Experiments
Garlic
Globulins - metabolism
Hematology
Immunization
Immunoglobulin G - blood
Immunoglobulin M - blood
Immunoglobulins
Immunomodulators
Infections
Interleukin-6 - blood
L-Lactate Dehydrogenase - blood
Laboratory animals
Male
Malondialdehyde - blood
Norfloxacin - therapeutic use
Nutrition
Oxidative stress
Pasteurella Infections - blood
Pasteurella Infections - drug therapy
Pasteurella multocida - drug effects
Pasteurella multocida - pathogenicity
Rabbits
Rodents
Sulfinic Acids - therapeutic use
Superoxide Dismutase - blood
Tumor Necrosis Factor-alpha - blood
Tumor necrosis factor-TNF
Veterinary medicine
title Anti-Inflammatory, Immunomodulatory, and Antioxidant Activities of Allicin, Norfloxacin, or Their Combination against Pasteurella multocida Infection in Male New Zealand Rabbits
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A44%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Inflammatory,%20Immunomodulatory,%20and%20Antioxidant%20Activities%20of%20Allicin,%20Norfloxacin,%20or%20Their%20Combination%20against%20Pasteurella%20multocida%20Infection%20in%20Male%20New%20Zealand%20Rabbits&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Aleya,%20Lotfi&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2018/1780956&rft_dat=%3Cproquest_pubme%3E2078582391%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c505t-de21d32908998ae550e2e97833340f22141aa5b87218a1d82afe9229db3e408f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2066306208&rft_id=info:pmid/30050645&rfr_iscdi=true